Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10036-2-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10036-2-AP, RRID:AB_2140439
- Product name
- MAPK7 antibody
- Antibody type
- Polyclonal
- Description
- MAPK7 antibody (Cat. #10036-2-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Proof-of-concept study investigating the role of S100P-RAGE in nasopharyngeal carcinoma.
p47phox deficiency impairs platelet function and protects mice against arterial and venous thrombosis.
Design, synthesis and molecular mechanisms of novel dual inhibitors of heat shock protein 90/phosphoinositide 3-kinase alpha (Hsp90/PI3Kα) against cutaneous melanoma.
The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.
Wang C, Wang X, Han A, Wang Y, Jiang H
Experimental and therapeutic medicine 2021 May;21(5):470
Experimental and therapeutic medicine 2021 May;21(5):470
p47phox deficiency impairs platelet function and protects mice against arterial and venous thrombosis.
Wang X, Zhang S, Ding Y, Tong H, Xu X, Wei G, Chen Y, Ju W, Fu C, Qi K, Li Z, Zeng L, Xu K, Qiao J
Redox biology 2020 Jul;34:101569
Redox biology 2020 Jul;34:101569
Design, synthesis and molecular mechanisms of novel dual inhibitors of heat shock protein 90/phosphoinositide 3-kinase alpha (Hsp90/PI3Kα) against cutaneous melanoma.
Qin F, Wang Y, Jiang X, Wang Y, Zhang N, Wen X, Wang L, Jiang Q, He G
Journal of enzyme inhibition and medicinal chemistry 2019 Dec;34(1):909-926
Journal of enzyme inhibition and medicinal chemistry 2019 Dec;34(1):909-926
The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.
Li Y, Zhang Z, Zhou X, Li L, Liu Q, Wang Z, Bai X, Zhao Y, Shi H, Zhang X, Ye L
Cancer letters 2014 Dec 28;355(2):288-96
Cancer letters 2014 Dec 28;355(2):288-96
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The MAPK7 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human MAPK7. This antibody recognizes human, mouse antigen. The MAPK7 antibody has been validated for the following applications: ELISA, WB analysis.